GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a remarkable development in how we approach type 2 diabetes . These new therapies help mimicking the body’s inherent GLP-1 substance , https://checkbookmarks.com/story7443588/glp-1-a-significant-breakthrough-in-blood-sugar-management